Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €94.00 ($104.44) price target by Berenberg Bank in a research note issued on Wednesday. The brokerage currently has a a “buy” rating on the stock.

Several other research analysts have also commented on the company. Goldman Sachs Group Inc. set a €94.00 ($104.44) target price on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. Kepler Capital Markets set a €95.00 ($105.56) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Monday, August 22nd. JPMorgan Chase & Co. set a €103.30 ($114.78) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Friday, September 2nd. Warburg Research set a €85.00 ($94.44) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Tuesday, August 2nd. Finally, Morgan Stanley set a €97.00 ($107.78) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Monday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of €88.97 ($98.86).

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Shares of Fresenius Medical Care AG & Co. (ETR:FME) opened at 79.30 on Wednesday. Fresenius Medical Care AG & Co. has a 12-month low of €67.50 and a 12-month high of €85.52. The firm has a 50-day moving average price of €80.85 and a 200 day moving average price of €77.97. The firm has a market cap of €24.25 billion and a price-to-earnings ratio of 21.98.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/berenberg-bank-reiterates-94-00-price-target-for-fresenius-medical-care-ag-co-pref-fme.html

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.